Greenlight Biosciences Holdings Pbc Asset Turnover Ratio (GRNA), as of first quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Greenlight Biosciences Holdings Pbc  (NASDAQ: GRNA)
 

Greenlight Biosciences Holdings Pbc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Greenlight Biosciences Holdings Pbc asset turnover ratio, the ability of Greenlight Biosciences Holdings Pbc's assets to generate revenue in the first quarter 2023, increased sequentially to 0.08 in the first quarter (Mar 31 2023), yet the ratio remained below the average, as GRNA's position remain challenging.

Within sector 51 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2023 compared to the preceding quarter from 3209 to 3225.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GRNA Asset Turnover Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Asset Change -6.44 % -28.2 % -26.59 % -52.67 % 67.94 %
Y / Y Revenue Change 1386.38 % 628.43 % 68.65 % - -20.92 %
Asset Turnover Ratio (TTM) 0.08 0.05 0.03 0.02 -0.01
GRNA's Total Ranking # 3225 # 3209 # 3530 # 3524 # 3975
Seq. Asset Change -23.12 % -2.35 % 55.05 % -19.62 % -41.01 %
Seq. Revenue Change 26.36 % 74.54 % -2.04 % 587.94 % -38.07 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 52
Healthcare Sector # 503
Overall Market # 3225

Asset Turnover Ratio Statistics
High Average Low
4.14 1.77 0.21
(Mar 31 2023)   (Mar 31 2022)




GRNA Company Profile • Back to GRNA Efficiency Comparisons • Compare GRNA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2023 Assets at quarter ending Mar 31 2023
Alpha Teknova Inc   0.25 $ 39.394  Millions$ 158.937  Millions
Sab Biotherapeutics Inc   0.25 $ 12.682  Millions$ 51.310  Millions
Twist Bioscience Corporation  0.25 $ 227.843  Millions$ 926.234  Millions
Cytomx Therapeutics Inc   0.24 $ 59.526  Millions$ 245.525  Millions
Standard Biotools Inc   0.24 $ 96.563  Millions$ 404.500  Millions
Cryoport inc   0.24 $ 247.792  Millions$ 1,041.744  Millions
Beone Medicines Ltd   0.24 $ 1,557.096  Millions$ 6,610.071  Millions
Valion Bio Inc   0.24 $ 1.893  Millions$ 8.048  Millions
Evoke Pharma Inc   0.23 $ 2.901  Millions$ 12.426  Millions
Clever Leaves Holdings Inc   0.23 $ 16.554  Millions$ 71.303  Millions
Quanterix Corporation  0.23 $ 103.194  Millions$ 449.203  Millions
Regen Biopharma Inc   0.23 $ 0.126  Millions$ 0.554  Millions
Aridis Pharmaceuticals Inc   0.23 $ 2.986  Millions$ 13.234  Millions
Dariohealth Corp   0.22 $ 27.595  Millions$ 122.718  Millions
Ionis Pharmaceuticals Inc   0.22 $ 575.972  Millions$ 2,574.300  Millions
Tvardi Therapeutics Inc   0.22 $ 43.242  Millions$ 193.899  Millions
Enanta Pharmaceuticals Inc  0.22 $ 81.176  Millions$ 365.620  Millions
Agenus Inc  0.22 $ 94.985  Millions$ 427.901  Millions
Personalis Inc   0.22 $ 68.680  Millions$ 310.180  Millions
Dyadic International Inc   0.22 $ 3.260  Millions$ 14.742  Millions
Adaptive Biotechnologies Corporation  0.22 $ 184.335  Millions$ 834.730  Millions
Jaguar Health Inc   0.22 $ 11.303  Millions$ 51.388  Millions
Adaptimmune Therapeutics Plc  0.22 $ 72.378  Millions$ 334.367  Millions
Bio rad Laboratories Inc   0.21 $ 2,779.031  Millions$ 12,977.417  Millions
Ligand Pharmaceuticals Incorporated  0.21 $ 194.531  Millions$ 925.159  Millions
Comera Life Sciences Holdings Inc   0.21 $ 0.931  Millions$ 4.449  Millions
Nutriband Inc   0.21 $ 2.079  Millions$ 10.047  Millions
Fortress Biotech Inc   0.21 $ 64.247  Millions$ 311.342  Millions
Cvrx inc   0.20 $ 26.032  Millions$ 127.060  Millions
Arbutus Biopharma Corp  0.20 $ 33.125  Millions$ 163.173  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.